News | News By Subject | News by Disease News By Date | Search News

Epilepsy News Articles

Get Our FREE
Industry eNewsletter
email:    
Top Breaking News
Up to 4,100 Children Victims of Sanofi (SNY)'s Epilepsy Drug, Says French Regulator     4/21/2017
Pfizer (PFE) Fined a Record $107 Million for Ramping Up Epilepsy Drug Price by as Much as 2,600%     12/7/2016
UCB Soars Most Since 2009 After US District Court Backs Epilepsy Drug Vimpat Patent     8/15/2016
10,000+ Women Took Sanofi (SNY)'s Anti-Epilepsy Drug Despite Risk to Fetuses     8/10/2016
GW Pharma (GWPH)’s Epidiolex Meets Primary Endpoint in Phase III     6/27/2016
In Light of Disappointing Trial Results, Acorda (ACOR) Terminates Epilepsy Drug Program     5/20/2016
GW Pharma (GWPH) Shares Double as Cannabis Drug Meets Goals in Phase III Study     3/15/2016
Christmas Comes Early to SAGE Therapeutics (SAGE) Investors as Company Accelerates Promising Pipeline Timeline     12/17/2015
FDA Seeks More Information on Zogenix (ZGNX)'s Phase III Study of ZX008     10/20/2015
Sun Pharma Group Stocks Dip on U.S. FDA Denial for its Epilepsy Drug     9/28/2015
Watchdog Accuses Pfizer (PFE) of Overcharging By Millions for Epilepsy Drug     8/6/2015
Zogenix (ZGNX) and FDA Delay Two Rare Epilepsy Trials by Three Months     7/15/2015
AmerisourceBergen Corporation (ABC) the “Pony to Ride” for Biosimilar Opportunities, Says UBS     3/16/2015
Analyst: Current Crop of Biotech IPOs a Mixed Bag of Low Market Caps, Little Data     12/3/2014
Best Value In Biotech? Actavis (ACT), Says UBS     11/17/2014

News from Around the Web
‘Mini-Me’ Brains-In-A-Dish Mimic Disease, Raise Hope For Eventual Therapies, Nature Reveals     4/27/2017
Flowonix Release: First Implantable Pump Delivers Drugs Directly Into Brains Of Epileptic Patients     3/17/2017
GW Pharma (GWPH) Is Set To Benefit As Cannabis Takes On Cancer     2/10/2017
France Launches Fund to Help Sanofi (SNY) Epilepsy Drug Victims     11/16/2016
Implant Halts Seizures, Memorial Healthcare System Study     10/12/2016
Marijuana-Based Drug Helps Kids With Rare Forms Of Epilepsy In Studies, GW Pharma (GWPH) Reveals     6/28/2016
Links Between Autism And Epilepsy Deepen, Karolinska Institute Study     6/16/2016
Heart Rate Variability Predicts Epileptic Seizure, Kumamoto University Study     4/4/2016
Type 1 Diabetes Linked To Epilepsy Risk, China Medical University Children's Hospital Study     4/1/2016
Changes In Heart Activity May Signal Epilepsy, Case Western Reserve University Study     3/10/2016
Wristband Detects And Alerts For Seizures, Monitors Stress, MIT Study     3/10/2016
Realizing The Promise Of Neuromodulation     3/4/2016
Smartwatch App Detects Epileptic Seizures And Texts A Warning     1/8/2016
Virtual Brain Surgery Could Personalise Epilepsy Treatment, Newcastle University Study     12/16/2015
New Personal Monitoring Devices For Epilepsy May Offer Alternatives To Inpatient Video EEG, University of Utah Study     12/7/2015

Press Releases
Pairnomix Teams Up With StemoniX To Co-Develop New Epilepsy Model     7/18/2017
The FDA Has Accepted An Orphan Designation Request For Use Of Truveta Administered Intranasally Submitted By Axium Pharmaceuticals     7/11/2017
Isodiol International Receives Regulatory (ANVISA) Approval For Isoderm For The Treatment Of Epilepsy And Parkinson's     7/6/2017
FDA Green Lights LivaNova (LIVN)'s VNS Therapy for Drug-Resistant Epilepsy in Kids     6/29/2017
Zogenix (ZGNX) Receives Orphan Drug Designation From FDA For ZX008 In Treatment Of Lennox Gastaut Syndrome     6/22/2017
GW Pharma (GWPH) Preps For NDA As Cannabis Drug Halved Convulsions In Kids With Rare Form Of Epilepsy     5/25/2017
NYU Langone Medical Center Release: Cannabis Derivative Cannabidiol Reduces Seizures In Severe Epilepsy Disorder     5/25/2017
Adamas Pharma (ADMS) Presents Positive Phase Ia Data Of ADS-4101 (Lacosamide) For The Treatment Of Partial Onset Seizures In Epilepsy     5/22/2017
Biscayne Pharma Readies Phase Ib Trial For Novel Antiepileptic Agent BIS-001 And Receives FDA Orphan Drug Designation For Dravet Syndrome     5/9/2017
Proximagen Limited Release: Midazolam Nasal Spray (Usl261) Phase III Trial Meets Primary Efficacy Endpoint In Patients With Seizure Clusters     4/27/2017
Eisai Inc. (ESALF.PK) Release: Meta-Analysis Of Published Trials Supports The Extrapolation Of Antiepileptic Drug Efficacy Data From Adult To Pediatric Patients With Primary Generalized Tonic-Clonic Seizures     4/27/2017
Xenon Pharma Expands Ion Channel Neurology Pipeline With Acquisition Of New Potassium Channel Modulator For The Treatment Of Epilepsy     4/26/2017
Epygenix Therapeutics Receives Orphan Drug Designation From The U.S. FDA For EPX-100 And EPX-200 In The Treatment Of Patients With Dravet Syndrome     4/25/2017
GW Pharma (GWPH) And Its U.S. Subsidiary Greenwich Biosciences Highlight New Epidiolex (Cannabidiol) Data Released By The American Academy of Neurology     4/19/2017
Texas A&M University Research Points To Potential Way To Prevent Seizure-Caused Brain Damage     4/11/2017

//-->